Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation
Nicolas Vallet, Sophie Le Grand, Louise Bondeelle, et al.
Blood (2022) Vol. 140, Iss. 23, pp. 2500-2513
Open Access | Times Cited: 22

Showing 22 citing articles:

ERS/EBMT clinical practice guidelines on treatment of pulmonary chronic graft-versus-host disease in adults
Saskia Bos, John Murray, Monia Marchetti, et al.
European Respiratory Journal (2024) Vol. 63, Iss. 3, pp. 2301727-2301727
Open Access | Times Cited: 9
The lung microbiome in interstitial lung disease
Sheridan G Mikhail, David N. O’Dwyer
Breathe (2025) Vol. 21, Iss. 2, pp. 240167-240167
Open Access | Times Cited: 1
Circulating T cell profiles associate with enterotype signatures underlying hematological malignancy relapses
Nicolas Vallet, Maud Salmona, Jeanne Malet-Villemagne, et al.
Cell Host & Microbe (2023) Vol. 31, Iss. 8, pp. 1386-1403.e6
Open Access | Times Cited: 12
The rewired immune microenvironment in leukemia
Zoe Ciantra, Varvara Paraskevopoulou, Iannis Aifantis
Nature Immunology (2025)
Closed Access
Tricking the Trickster: Precision Medicine Approaches to Counteract Leukemia Immune Escape after Transplant
Annalisa Tameni, Cristina Toffalori, Luca Vago
Blood (2024) Vol. 143, Iss. 26, pp. 2710-2721
Closed Access | Times Cited: 3
Cell Therapy Transplant Canada (CTTC) Consensus-Based Guideline 2024 for Management and Treatment of Chronic Graft-Versus-Host Disease and Future Directions for Development
Dennis Dong Hwan Kim, Gizelle Popradi, Kylie Lepic, et al.
Current Oncology (2024) Vol. 31, Iss. 3, pp. 1426-1444
Open Access | Times Cited: 2
Effects of Azithromycin on Blood Inflammatory Gene Expression and Cytokine Production in Sarcoidosis
Simon Fraser, Susannah Thackray-Nocera, Caroline Wright, et al.
Lung (2024) Vol. 202, Iss. 5, pp. 683-693
Open Access | Times Cited: 2
A mini‐review on anticancer‐related properties of azithromycin and its potential activities in overcoming the challenges of glioblastoma
Siti Nazihahasma Hassan, Abdul Aziz Mohamed Yusoff, Zamzuri Idris, et al.
Fundamental and Clinical Pharmacology (2023) Vol. 37, Iss. 5, pp. 918-927
Closed Access | Times Cited: 5
Antimicrobial Stewardship in Immunocompromised Patients
Jonathan Hand, Hannah Imlay
Infectious Disease Clinics of North America (2023) Vol. 37, Iss. 4, pp. 823-851
Closed Access | Times Cited: 5
The intestinal microbiota and cellular therapy: implications for impact and mechanisms
Jiayi Xie, Melody Smith
Blood (2024) Vol. 144, Iss. 15, pp. 1557-1569
Closed Access | Times Cited: 1
Azithromycin targets the CD27 pathway to modulate CD27hi T-lymphocyte expansion and type-1 effector phenotype
Abdul W. Ansari, Manju Nidagodu Jayakumar, Fareed Ahmad, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Azithromycin inhibits the intracellular persistence of Acinetobacter baumannii by inducing host cell autophagy in human bronchial epithelial cells
Bo Weng, Yuliang Li, Wei Feng, et al.
Microbial Pathogenesis (2024) Vol. 198, pp. 107152-107152
Closed Access | Times Cited: 1
Bacterial Pathogens Causing Pneumonia Post Hematopoietic Stem Cell Transplant: The Chronic GVHD Population
Said Chaaban, Andrea Zimmer, Vijaya Raj Bhatt, et al.
Pathogens (2023) Vol. 12, Iss. 5, pp. 726-726
Open Access | Times Cited: 1
Noninfectious Pulmonary Complications
Anne Bergeron, Kenneth R. Cooke
Springer eBooks (2024), pp. 471-480
Closed Access
Pulmonary GvHD: is it time to change the NIH diagnostic criteria?
Martina Canichella, Paolo de Fabritiis
Clinical Hematology International (2024) Vol. 6, Iss. 4
Open Access
CSF-1R blockade to alleviate azithromycin mediated immunosuppression in a mouse model of intracellular infection
Shivani Yadav, Sharath Gowda, Reena Agrawal-Rajput
International Immunopharmacology (2024) Vol. 143, pp. 113477-113477
Closed Access
mTOR inhibitors potentially preserve fertility in female patients with haematopoietic malignancies: a narrative review
Yuji Tanaka, Tsukuru Amano, Akiko Nakamura, et al.
Annals of Hematology (2024)
Closed Access
Association between early anti-cytomegalovirus therapy and the incidence of chronic graft-versus-host disease
Kotaro Miyao, Makoto Murata, Tetsuya Nishida, et al.
International Journal of Hematology (2024)
Closed Access
Biology of post-transplant relapse: actionable features
Giorgio Orofino, Luca Vago
Hematology (2024) Vol. 2024, Iss. 1, pp. 736-743
Closed Access
Pulmonary and Critical Care Considerations in Pediatric Hematopoietic Stem Cell Transplantation Patient
Yiouli P. Ktena, Kenneth R. Cooke
Springer eBooks (2023), pp. 403-425
Closed Access
Disseminated nontuberculous mycobacterial infection prior to hematopoietic stem cell transplantation: A case of successful treatment
Daisuke Ikeda, Kosei Matsue
Transplant Infectious Disease (2023) Vol. 25, Iss. 5
Closed Access
What a “harmless” antibiotic can teach us about GVL
Katie Maurer, Robert J. Soiffer
Blood (2022) Vol. 140, Iss. 23, pp. 2420-2422
Open Access
Page 1

Scroll to top